amygdalin has been researched along with Bladder Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartsch, G; Blaheta, RA; Haferkamp, A; Juengel, E; Kaulfuss, S; Makarević, J; Reiter, M; Rutz, J; Tsaur, I | 1 |
Blaheta, RA; Haferkamp, A; Juengel, E; Kaulfuss, S; Makarević, J; Nelson, K; Pfitzenmaier, J; Rutz, J; Tsaur, I | 1 |
Epenetos, AA; Rowlinson-Busza, G; Syrigos, KN | 1 |
3 other study(ies) available for amygdalin and Bladder Cancer
Article | Year |
---|---|
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2.
Topics: Amygdalin; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin-Dependent Kinase 2; G1 Phase; Humans; Proto-Oncogene Proteins c-akt; Resting Phase, Cell Cycle; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2014 |
Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
Topics: Amygdalin; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Movement; Chemotaxis; Endothelial Cells; Flow Cytometry; Gene Expression; Gene Knockdown Techniques; Humans; Integrins; RNA, Small Interfering; Urinary Bladder Neoplasms | 2014 |
In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody.
Topics: Amygdalin; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; beta-Glucosidase; Cell Survival; Enzyme-Linked Immunosorbent Assay; Humans; Prodrugs; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1998 |